Company profile: Morphic Therapeutics
1.1 - Company Overview
Company description
- Provider of oral integrin therapies in development to treat serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer; developing treatments for patients with immunological, fibrotic, neoplastic, and vascular diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Morphic Therapeutics
Avila Therapeutics
HQ: United States
Website
- Description: Provider of covalent drugs for viral infections, cancers, and autoimmune diseases, designing and developing targeted small-molecule therapies including AVL-181, a hepatitis C virus protease inhibitor; partnered with Sanofi-Aventis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avila Therapeutics company profile →
Ariad Pharmaceuticals
HQ: United States
Website
- Description: Provider of oncology medicines, focused on the discovery, development and commercialization of treatments for cancer patients, including Iclusig for certain types of leukemia targeting cancer cells with specific genetic mutations; based in Cambridge, Massachusetts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ariad Pharmaceuticals company profile →
Dako
HQ: Denmark
Website
- Description: Provider of reagents, instruments, and software for cancer diagnostics to hospital and research laboratories, offering pathology solutions including diagnostic antibodies, IHC/ISH and flow cytometry reagents; staining and image analysis instruments; molecular and companion diagnostics; and pharmacodiagnostic kits (pharmDx).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dako company profile →
Nativis
HQ: United States
Website
- Description: Provider of therapeutic modalities in development for the treatment of serious disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nativis company profile →
Immunovia
HQ: Sweden
Website
- Description: Provider of blood-based diagnostics for early detection of pancreatic cancer, conducting clinical trials and validation studies to ensure accuracy and reliability, and collaborating with medical institutions and research centers globally to validate its diagnostic tests and bring them to market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunovia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Morphic Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Morphic Therapeutics
2.2 - Growth funds investing in similar companies to Morphic Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Morphic Therapeutics
4.2 - Public trading comparable groups for Morphic Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →